IBRN Holdings Information

IBRN is an equity ETF with a total of 80 individual holdings. The top holdings are Praxis Precision Medicines stock at 5.42%, Dianthus Therapeutics at 5.41%, ACADIA Pharmaceuticals at 4.78%, Xenon Pharmaceuticals at 4.53%, and Scholar Rock Holding at 4.45%.

Total Holdings

Top 10 Percentage

44.81%

Asset Class

Equity

ETF Category

Health

Assets

7.92M

PE Ratio

16.48

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	PRAX	Praxis Precision Medicines, Inc.	5.42%	1,157
2	DNTH	Dianthus Therapeutics, Inc.	5.41%	3,652
3	ACAD	ACADIA Pharmaceuticals Inc.	4.78%	13,265
4	XENE	Xenon Pharmaceuticals Inc.	4.53%	5,685
5	SRRK	Scholar Rock Holding Corporation	4.45%	6,638
6	ARWR	Arrowhead Pharmaceuticals, Inc.	4.45%	4,021
7	ALKS	Alkermes plc	4.30%	6,870
8	BIIB	Biogen Inc.	4.03%	1,505
9	PTCT	PTC Therapeutics, Inc.	3.80%	4,145
10	DNLI	Denali Therapeutics Inc.	3.64%	11,666
11	ARGX	argenx SE	3.59%	330
12	NBIX	Neurocrine Biosciences, Inc.	3.50%	1,793
13	EWTX	Edgewise Therapeutics, Inc.	3.47%	6,153
14	AXSM	Axsome Therapeutics, Inc.	3.45%	1,265
15	DYN	Dyne Therapeutics, Inc.	3.40%	10,352
16	SUPN	Supernus Pharmaceuticals, Inc.	2.63%	4,269
17	AXGN	Axogen, Inc.	2.52%	4,054
18	KRX: 326030	SK Biopharmaceuticals Co., Ltd.	2.41%	3,060
19	BHVN	Biohaven Ltd.	1.84%	9,836
20	SRPT	Sarepta Therapeutics, Inc.	1.84%	7,938
21	ASX: NEU	Neuren Pharmaceuticals Limited	1.82%	8,580
22	HLBBF	H. Lundbeck A/S	1.77%	21,005
23	STO: BIOA.B	BioArctic AB (publ)	1.43%	3,341
24	TSHA	Taysha Gene Therapies, Inc.	1.42%	18,665
25	RAPP	Rapport Therapeutics, Inc.	1.35%	2,230

Showing 25 of 80 holdings

Subscribe to see the full list

Activate Now

As of Aug 14, 2026